Corresponding Projections for Orphan Screening by Giesselbach, Sven et al.
Corresponding Projections for Orphan Screening
Sven Giesselbach1,2, Katrin Ullrich3, Michael Kamp2,3, Daniel Paurat1,2, and Thomas Ga¨rtner4
1Fraunhofer IAIS
2Competence Center Machine Learning Rhine-Ruhr
3University of Bonn
4University of Nottingham
{sven.giesselbach,daniel.paurat}@iais.fraunhofer.de
{ullrich@iai,kamp@cs}.uni-bonn.de
thomas.gaertner@notthingham.ac.uk
Abstract
We propose a novel transfer learning approach for orphan screening called corre-
sponding projections. In orphan screening the learning task is to predict the bind-
ing affinities of compounds to an orphan protein, i.e., one for which no training
data is available. The identification of compounds with high affinity is a central
concern in medicine since it can be used for drug discovery and design. Given a
set of prediction models for proteins with labelled training data and a similarity
between the proteins, corresponding projections constructs a model for the orphan
protein from them such that the similarity between models resembles the one be-
tween proteins. Under the assumption that the similarity resemblance holds, we
derive an efficient algorithm for kernel methods. We empirically show that the
approach outperforms the state-of-the-art in orphan screening.
1 Introduction
This paper proposes an approach to predicting binding affinities of compounds to a protein without
training data. In biological organisms the bindings of small compounds to proteins induce subse-
quent cellular reactions. The strength of this binding is expressed via a real-valued affinity. In the
context of affinity prediction, we refer to compounds as ligands. Protein-ligand-complexes regulate
a variety of biochemical processes, e.g., the effectiveness of transporters, ion channels, hormones,
receptors, and enzymes. To know whether or how strong a ligand binds to a protein is crucial
for drug discovery and design. The identification of ligands with high affinity for new drug sub-
stances is a central concern in medicine [8]. Via high-throughput screening (HTS) machinery in
laboratories one is able to determine ligand affinities practically. In order to supplement this time-
consuming and cost-intensive procedure, molecular databases can be screened with computational
methods [1, 6, 11, 24], denoted in-silico virtual screening [19].
Ligands can be represented by molecular fingerprints [2], i.e., vectorial representations that com-
prise their structural or physico-chemical information. For a protein with a training set of ligands
and their binding affinities, this allows to train a prediction model using similarity search [5] and
various machine learning approaches, e.g., random forests or neural networks [3, 9, 10, 12]. The
most prominent and successful methods so far are support vector machines (SVM) using molecular
fingerprints [5, 13, 20, 21, 22].
This paper tackles an even more challenging task called orphan screening [23]. It describes the pre-
diction of ligand affinities for proteins without known ligand affinity values (orphan targets), such as
Machine Learning for Health (ML4H) Workshop at NeurIPS 2018.
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Figure 1: Overview of the correspond-
ing projections approach (CP). The goal
is to find a hypothesis ho for the orphan
target to using a set of supervised tar-
gets t1, . . . , tn with labelled training sets
E1, . . . , En. For each ti with i ∈ [n],
a model hi is trained using Ei, e.g., by
SVR. The CP algorithm uses these pro-
teins and models, as well as a similarity
measure kT between targets and a sim-
ilarity measure kH between models to
construct ho.
G-protein coupled receptors (GPCRs) which are popular
drug targets with few or no identified ligands [4, 8]. Note
that in previous work on orphan screening (see, e.g., [3,
4, 5, 8, 14, 23]), only those compounds with an affinity
above a predifined threshold are called ligands and the
task is to classifiy a compound as ligand or non-ligand.
In the present work, we consider the regression case, i.e.,
the direct prediction of the binding affinities. Thus, for
simplicity we refer to every compound as ligand.
The state-of-the art in orphan screening is the application
of support vector machines with target-ligand-kernels
(TLK) [7]. The TLK is a tensor product of a target ker-
nel and a ligand kernel. Thus, it serves as similarity mea-
sure for target-ligand-pairs and allows for a simultaneous
screening of proteins and ligands in chemogenomics [8].
We present a novel transfer learning approach [15] called
corresponding projections (CP) for orphan screening.
The idea behind CP is to relate the projections of pro-
teins to the projections of the corresponding prediction
models. Their relationship is used to generate a model
for the orphan target. Just like the TLK approach, the
CP requires that labelled training information for other
proteins (supervised targets) is available for which a pre-
diction model can be trained. Subsequently, in the actual
CP optimisation step a prediction model is assigned to
the orphan target such that its relationship to the given
models resembles the relationship of the orphan protein
to the given ones (see Fig. 1). The following section
defines CP for affinity prediction using support vector
regression (SVR) as supervised training method.
In Sec. 3 the CP approach is empirically evaluated on an
orphan screening task and compared to TLK and other
baselines, including a simplified variant of CP, i.e., a tar-
get similarity-weighted sum of supervised models introduced in [5]. Sec. 4 concludes the paper. The
solutions of CP variants with proof and further practical result can be found in the appendix.
2 Corresponding Projections
Given a set of n ∈ N target proteins t1, . . . , tn ∈ T with corresponding training sets E1, . . . , En,
each consisting of labelled examples
Ei = {(x1, y1), . . . , (xm, ym)} ⊂ X × Y
with i ∈ [n], a model hi : X 7→ Y ∈ H can be trained for each target, e.g., via SVR. Thus, we obtain
pairs (t1, h1), . . . , (tn, hn) ∈ T ×H. Furthermore, let to ∈ T denote the orphan protein for which
we want to infer a model ho ∈ H.
For that, let 〈, 〉T and 〈, 〉H be inner products with associated norms for targets t ∈ T and models
h ∈ H. We assume that the projection of proteins resembles the projection of models, i.e.,
〈ti, to〉T
‖ti‖T ≈
〈f(ti), f(to)〉H
‖f(ti)‖H (1)
for every supervised target ti. With this, finding ho can be solved by a least squares approach.
Definition 1. The model for the orphan protein ho is given by ho = argminh∈HQo(h), where
Qo(h) = ν‖h‖2H +
n∑
i=1
|〈h, hi〉H‖ti‖T − 〈to, ti〉T ‖hi‖H|2 , (2)
with trade-off parameter ν ≥ 0. The optimisation in (2) is called corresponding projections (CP).
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If H is a Hilbert space, the model ho lies in the span of the supervised hypotheses h1, . . . , hn, i.e.,
ho =
∑n
i=1 βoihi for appropriate βo ∈ Rn. This parametrisation of ho leads us to a solution of CP.
Lemma 2. Let H be a Hilbert space and kT a similarity measure on the target space T . CP in (2)
can be solved via
βo = [νG+GNG]
†Gρo,
where [M ]† denotes the Moore-Penrose inverse of matrix M and
N = diag({kT (ti, ti)}ni=1)
G ={〈hi, hj〉H}ni,j=1
ρo ={
√
kT (ti, ti) kT (to, ti)‖hi‖H}ni=1 .
The proof of Lemma 2 and more theoretical details can be found in Appendix A.1.
3 Empirical Evaluation
We evaluate the proposed CP approach on an orphan screening task and compare it to state-of-the
art baselines. For that, we use 9 protein-ligand datasets extracted from BindingDB (bindingdb.
org). Each dataset corresponds to a human protein with peptidase domain and comprises between
240 and 2649 ligands with affinity labels (pKi-values) towards the respective protein. We utilise
the standard molecular fingerprint ECFP4 [16] for the representation of ligands. Target similarities
were calculated from the amino acid sequence similarity of the peptidase domain. We normalise the
similarities of all targets except for the respective orphan to sum to 1.
The parameter ν of the optimisation problem (Eq. 10) was determined on an independent training
set and fixed to ν = 5 for all orphan targets. To improve the numerical stability of inversion of
νG+GNG, we add a constant λ ∈ R+ to the diagonal of the matrix. That is, we consider a slightly
different CP optimisation
βo = [νG+ λIn +GNG]
†Gρo ,
with λ = 1 for all orphan targets 1.
In order to perform orphan screening, we perform a leave-one-out cross validation over all proteins,
hence considering each protein as orphan once. We report the root mean squared error (RMSE) of
the predicted affinities. In order to test for stability of the method, we create 10 distinct draws of
the dataset by randomly sampling 240 ligands per protein. The reported RMSE is an average over
the 10 draws per orphan protein. In accordance with state-of-the-art approaches we use the linear
kernel for our experiments. The models for the supervised targets are trained using SVR. A 3-fold
cross-validation is used to obtain the best hyperparameters for each target with parameter ranges
 ∈ {0.1, 0.01, 0.001} and regularisation parameter C ∈ {2−i : i ∈ {−5,−4, . . . , 4, 5}}. More
details on the experimental setup can be found in section A.2.
Fig. 2 shows the RMSE of all approaches averaged over all orphan proteins and all draws. CP
achieves a median RMSE of 2.197. We compare CP with trivial and state-of-the-art baselines:
A naive way of combining target models without considering similarities of targets is to build a
simple average over them and use the averaged model (Avg) to predict the ligand affinities for the
orphan target. However, we find that Avg performs significantly worse than CP with a median
RMSE of 3.610.
The most straight-forward way of using protein similarities is to choose models of other targets
according to their similarity to the orphan target. To understand the range of how proximity of
proteins affects the prediction quality we evaluate the performance of models from the targets closest
to and farthest from the orphan. The model of the most similar target (Closest Protein) outperforms
Avg, while its median RMSE of 2.427 is significantly higher than the median RMSE of CP. Note
that using the model of the least similar protein (Farthest Protein) yields a median RMSE of 3.203,
worse than CP but still better than Avg.
The fact that Closest Protein performs better supports the intuition that the orphan and targets closer
to it share similar traits which determine the affinities of ligands. Reducing Avg to a model using just
1The code can be found at bitbucket.org/grumpy_kat/corresponding-projections.
3
the 3 closest targets (Avg-Clo-3) yields a significant performance boost, indicating that it benefits
from the focus on closer proteins. With a median RMSE of 2.260 it outperforms Closest Protein.
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Figure 2: RMSEs of the proposed CP
approach for all 9 proteins and 10 draws
in comparison to the baselines.
Rather than completely omitting the targets which are not
among the 3 closest, the state-of-the-art approach TLK in-
corporates target similarities via features which are com-
posed of joint target and ligand kernels. The hyperpa-
rameters for TLK are again optimised via grid search and
3-fold crossvalidation on all supervised targets using the
same parameter ranges as above. TLK achieves a median
RMSE of 2.934, placing it between Closest and Farthest.
The TLK-variant (TLK-Clo-3) which also uses just the
3 closest proteins suffers from reduced training data size
and achieves a median RMSE of 3.708, worse than the
original TLK and even worse than Avg.
Other than the previous approaches, CP optimizss the
weights of each model to resemble the similarities of the
targets, thereby making use of all available models. The
results suggest that incorporating the similarities in the
target and hypothesis space is beneficial: Not only is
CP’s median RMSE lower that that of simpler schemes
like Avg-Clo-3, it also outperforms the state-of-the-art ap-
proach TLK.
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Figure 3: The RMSE of Simplified
and CP averaged over all proteins and
draws.
The approach closest to CP is a simplified weighted aver-
age of models (for further details see Def. 6 in Sec. A.1 of
the appendix). Simplified outperforms the other baseline
approaches, but Fig. 3 shows that it performs worse than
CP, indicating that the optimisation step of CP yields a
better model than the plain integration of the similarities.
4 Conclusion and Future Work
We introduced corresponding projections, a transfer
learning based approach to hypothesis finding for un-
labelled target domains that incorporates target and hy-
pothesis similarities to derive a model for an orphan tar-
get. We applied the algorithm to the problem of target-
ligand affinity prediction and empirically demonstrated
its superior performance over the current state-of-the-art
approach of using support vector regression with target-
ligand-kernels.
For future work we will expand our evaluation of corresponding projections to further tasks, such
as domain adaptation in natural language processing. We will also investigate how the proximity of
targets affects the quality of predictions.
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A Appendix
A.1 Corresponding Projections Theory
In this theoretical part of the appendix we present variants of the CP optimisation as defined in
Def. 1 as well as their corresponding solutions. We start with a linear version of corresponding
projections, then we derive a simplified version and lastly we introduce the more general non-linear
corresponding projection which we evaluated in this paper.
Linear and Simplified Algorithm
At first we turn towards the case H = Rd with the canonical inner product, i.e., we consider linear
functions of d-dimensional input vectors. We denote this CP version linear corresponding pro-
jections (LCP). As a preparation for the following result we define the matrices H ∈ Rd×n and
N ∈ Rn×n via
H = (h1| · · · |hn), N = diag(kT (ti, ti)), (3)
as well as the vectors ρo, δo ∈ Rn with
{δo}i = kT (to, ti)‖hi‖d, {ρo}i =
√
kT (ti, ti){δo}i, (4)
where ‖ · ‖d is the Euclidean norm in Rd.
Lemma 3. Let (t1, h1), . . . , (tn, hn) ∈ T ×H be examples of targets and corresponding hypotheses.
IfH = Rd and kT a similarity measure, LCP can be solved as follows
f(to) =
[
νId +
n∑
i=1
hikT (ti, ti)hTi
]†
(5)
·
n∑
i=1
hi‖hi‖d
√
kT (ti, ti)kT (to, ti),
where † is the Moore-Penrose inverse of a square matrix.
Proof. We formulate the objective Qo(h) in Def. 1 with H,N, ρo, and δo from above.
Qo(h) = νhTh+ hTHNHTh− 2hTHρo + δoT δo
The solution of LCP in (5) can be derived by setting the gradient of Qo(h)
∂Qo
∂h
= 2νh+ 2HNHTh− 2Hρo
equal to zero. We obtain ho = [νId +HNHT ]†Hρo.
As the matrixHNH from above is positive semi-definite, the inverse [νId+HNH]−1 always exists
if ν is positive. Otherwise, the more general [·]† will be applied.
Subsequent to the linear version LCP we define a simplified CP variant.
Definition 4. Let (t1, h1), . . . , (tn, hn) ∈ T × H be supervised targets and their hypotheses. For
an arbitrary similarity function kT on targets we define simplified corresponding projections (SCP)
according
f(to) =
n∑
i=1
hi
kT (to, ti)√
kT (ti, ti)
. (6)
In the naı¨ve SCP approach the orphan hypothesis ho is a linear combination of supervised hypotheses
hi with coefficients that have not to be learned beforehand. The coefficients in (6) are essentially the
left hand side of the CP initial equation in (1). Therefore, the complexity of SCP is onlyO(|T |dκ) if
the cost for kT is bounded by κ. In contrast, the complexity for the calculation of (5) is O(|T |d2κ).
Actually, for SCP the candidate space H is not necessarily equal to Rd, but an arbitrary function
7
space. A similar approach to SCP for classification already appeard in [5], where the authors also
applied a weighted sum of predictors denoted as SVM linear combination (SVM-LC).
Non-Linear Corresponding Projections
In the last section we considered a linear as well as a simplified version of CP. Now we want to
exploit that H is a Hilbert space with general inner product 〈·, ·〉 and corresponding norm ‖ · ‖. In
this scenario we conclude a representation of ho as linear combination
ho =
n∑
i=1
βoihi , βo ∈ Rn, (7)
i.e, ho lies in the span of the supervised hypotheses h1, . . . , hn. This can be shown with an ar-
gumentation similar to the proof of the representer theorem (RT) [17]. To this aim, let us con-
sider the decomposition ho = s + g, where s ∈ span{h1, . . . , hn} and 〈g, s′〉H = 0 for all
s′ ∈ span{h1, . . . , hn}. Then we obtain
= ν‖s+ g‖2 +
n∑
i=1
[〈s+ g, hi〉
√
kT (ti, ti)
− kT (to, ti)‖hi‖ ]2
≥ ν‖s‖2 +
n∑
i=1
[〈s, hi〉
√
kT (ti, ti)− kT (to, ti)‖hi‖ ]2,
which shows the claim. Analogous to (3) and (4), we consider matrices G,N ∈ Rn×n with general
inner product
{G}i,j = 〈hi, hj〉H, N = diag(kT (ti, ti)) (8)
and vectors ρo, δo ∈ Rn
{δo}i = kT (to, ti)‖hi‖H, {ρo}i =
√
kT (ti, ti) {δo}i. (9)
We identify ho with its defining vector βo ∈ Rn.
Lemma 5. Let H be a Hilbert space and kT a similarity measure on the target space T . With the
representation of ho in (7) CP from Def. 1 can be solved as
βo = [νG+GNG]
†Gρo , (10)
where N , G, and ρo are defined as in (8) and (9).
Proof. With (7), (8), and (9) the objective in Def. 1 can be written
Qo(β) = νβTGβ + βTGNGβ − 2βTGρo + (δo)T δo.
Its gradient ∂Qo/∂β set to zero shows βo = [νG+GNG]†Gρo.
This constitutes the approach used throughout the paper. Solving Eq. 10 requires inverting an n× n
matrix and thus has a computational complexity of O(n3).
Note that in practice it can happen that the the union of ligands for all supervised targets q is smaller
than the number supervised targets n. This can happen, e.g., if every supervised target has the same
small training set of ligands and n is larger than this training set. For this case, the CP solution
according to Eq. 10 can be rewritten such that it can be solved in time O(q3). For that we require
thatH is a reproducing kernel Hilbert space (RKHS)
H =
{
h(·) =
∞∑
i=1
piikH(xi, ·) : xi ∈ X , αi ∈ R
}
,
where kH defined on X ×X is the reproducing kernel ofH (for more details see, e.g., [17, 18]). As-
sume now that each hypothesis hi arised from a training process with training examples from X ×Y
solving a regularised cost function like the one applied for regularised empirical risk minimisation.
Actually, the set of training instances and according labels depends on the respective supervised
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target ti. Let {x1, . . . , xq} be the union of the training instances for all targets ti, i = 1, . . . , n, and
K the Gram matrix of kernel kH. The parameterised representation of each hypothesis hi
hi(x) =
q∑
j=1
piijkH(xj , x) , x ∈ X , pii ∈ Rq, (11)
exists according to the RT. If xj was not in the set of the original training instances of ti the parameter
piij is just equal to zero. We cannot apply the RT for the orphan target to and its hypothesis ho
directly because of the lack of training examples. However, ho can be represented equivalently with
coefficients pio ∈ Rq as we have the representation in (7)
ho(x) =
n∑
i=1
βoihi(x) =
n∑
i=1
βoi
 q∑
j=1
piijkH(xj , x)
 (12)
=
q∑
j=1
(
n∑
i=1
βoipiij
)
kH(xj , x) =
q∑
j=1
piojkH(xj , x),
where βo ∈ Rn and pii, pio ∈ Rq . Hence, with Π = (pi1| · · · |pin) the coefficients of the orphan
target are pio = Πβo. Analogous to the CP solution in (10) we define the matrices G˜ ∈ Rq×n and
N ∈ Rn×n
G˜ = KΠ, N = diag(kT (ti, ti)) (13)
and vectors ρ˜o, δ˜o ∈ Rn
{δ˜o}i = kT (to, ti)
√
piTi Kpii, {ρ˜o}i =
√
kT (ti, ti) {δ˜o}i (14)
Again, we identify ho with its vector of coefficients pio.
Lemma 6. Let hi, i = 1, . . . , n, and ho have the representations (11) and (12) from above with
pii, pio ∈ Rq . With kH and kT we denote the reproducing kernel of H and a similarity measure on
the target space T , as well as K be the Gram matrix with respect to x1, . . . , xq . With (11) and (12)
CP can be solved as
pio =
[
νK +
n∑
i=1
KpiikT (ti, ti)piTi K
]†
·
n∑
i=1
(√
piTi Kpii
√
kT (ti, ti)kT (to, ti)
)
Kpii, (15)
where ν ≥ 0 and ti, i = 1, . . . , n, are the supervised targets. We call this approach kernel corre-
sponding projections (KCP).
Proof. The proof is again a consequence of the stationarity of the gradient of the parameterised
objective
Qo(pi) = νpiTKpi + piT G˜NG˜Tpi − 2piT G˜ρ˜o + δ˜oT δ˜o
from Def. (1).
Solving Eq. 15 requires inverting a q × q matrix and thus has a computational complexity in O(q3).
As mentioned above, this is preferable to solving Eq. 10 for n q.
A.2 Extended Experimental Results
In this section we provide information on the results with supervised baselines.
We also evaluated a hypothetical supervised case in which we trained an SVR on several fractions
(5%, 10%, 30%, 50%, and 80%) of the available ligands, testing it on remaining ones. This yields
an upper bound for the RMSE. On average all supervised models clearly outperform CP. However,
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Method Median RMSE
CP 2.197
Supervised-5% 1.797
Supervised-10% 1.440
Supervised-30% 1.140
Supervised-50% 1.038
Supervised-80% 0.946
Table 1: Median RMSE of CP and the supervised approaches over all draws, averaged over all
proteins.
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Figure 4: The RMSE of the unsupervised and supervised approaches over all draws for two proteins
protein P00750 and P07858.
they solve a different task, since CP assumes no labelled data for the orphan target. Notably, the
performance of CP is a lot closer to the supervised approaches, than TLK. For Supervised 50% the
median RMSE of CP is larger than Supervised 50% by a factor of 2, while TLKs median RMSE
is larger by a factor of almost 3. A more detailed investigation of the results, shows that CPs
performance varies strongly depending on the orphan target. Fig. 4(a) shows the performance for
the protein named P00750. We can observe that CP outperforms both the supervised model trained
on 5% and on 10% of the data, reaching a performance close to a supervised model trained on
30% of the data. Contrary Fig. 4(b) shows that for protein P07858 CP is worse than all supervised
approaches and the model of the farthest protein performs best out of all unsupervised approaches,
nearly as good as the supervised model trained on 10% of the data. In total CP performs better than
Supervised-5% for 4 proteins, better than Supervised-10% for 2 proteins, comparable to Supervised-
5% for 1 protein and significantly worse than all supervised approaches for 4 proteins.
This raises open research questions left for future work. One question is whether the chosen simi-
larity measure for target similarities is suitable or whether other similarity measures would perform
better. Another one is whether the performance of CP increases with the number of ligands per
protein or the total number of proteins. Since the performance of CP varies between proteins, an-
other question is whether this performance can be related to the similarity of the orphan target and
supervised ones.
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